Table 3 Patients with a large tumor bed volume: Whole Breast (WB) and Planning Treatment Volume (PTV) exposure after APBI treatment planning (1) in phase II trial; (2) non-coplanar and (3) mixed modalities.
Whole breast | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Usual dosimetric constraints | (1) | (2) | (3) | |||||||
Patient 1 | Patient 2 | Patient 3 | Patient 1 | Patient 2 | Patient 3 | Patient 1 | Patient 2 | Patient 3 | ||
V16 | 24 - 57 | 56.4 | 64.6 | 58.3 | 63.8 | 61.6 | 62.8 | 61.2 | 58.9 | 62.4 |
V20 | 23 - 54 | 54.4 | 63.4 | 56.1 | 58.9 | 57.1 | 59.5 | 51.4 | 52.2 | 56.9 |
V32 | 21 - 50 | 47.6 | 56.8 | 51.7 | 40.7 | 42 | 43.5 | 39.6 | 39.5 | 43.2 |
PTV coverage | ||||||||||
Usual dosimetric constraints | (1) | (2) | (3) | |||||||
Patient 1 | Patient 2 | Patient 3 | Patient 1 | Patient 2 | Patient 3 | Patient 1 | Patient 2 | Patient 3 | ||
V38 | 99 - 100 | 93.5 | 100 | 100 | 100 | 100 | 100 | 99.9 | 99.9 | 100 |
V40 | 95 - 100 | 60.6 | 93.5 | 98.7 | 99.3 | 100 | 99.2 | 95.3 | 94.5 | 96.7 |